文献速递冠心病外科

左主干病变PCI与CABG的荟萃分析

Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: A meta-analysis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2020-04-15

该系统综述与荟萃分析纳入5项随机试验共4595例左主干病变患者,比较药物洗脱支架PCI与CABG的结局。30天和1年时PCI卒中率更低、重复血运重建更高,死亡与心梗风险相似;5年时PCI心梗和重复血运重建风险更高,死亡与卒中无差异。

要点

  • 左主干病变PCI与CABG在早期及5年死亡率无显著差异
  • PCI在30天和1年卒中率更低,但重复血运重建更高
  • 5年时PCI心梗和重复血运重建风险显著高于CABG

核心结论

  • 左主干病变接受PCI或CABG治疗的患者在早期或5年死亡率上无显著差异。
  • CABG在30天和1年时卒中率更高,而PCI在5年时心梗和重复血运重建需求增加。

研究设计与样本

  • 系统综述与荟萃分析,检索至2020年1月的在线电子数据库,纳入比较药物洗脱支架PCI与CABG的随机试验。
  • 共纳入5项随机试验、4595例左主干冠状动脉疾病患者,采用固定效应模型计算比值比和95%置信区间。

主要发现

  • 30天和1年时,PCI与更低的卒中发生率、更高的重复血运重建率相关,死亡与心梗的比值比相似。
  • 5年时,PCI与更高的心梗率相关(比值比1.43;95%CI 1.13-1.79;P=.003)。
  • 5年时,PCI与更高的重复血运重建率相关(比值比1.89;95%CI 1.58-2.26;P<.001)。
  • 30天时PCI与更低的围术期心梗相关,而5年时PCI与更高的非围术期心梗相关(比值比2.32;95%CI 1.62-3.31;P<.001)。
  • 5年随访时死亡率和卒中率无差异。

临床怎么用

  • 左主干病变血运重建决策需权衡PCI的重复血运重建和晚期心梗风险与CABG的早期卒中风险。
  • 对于卒中高风险患者,PCI在30天和1年时卒中率更低可能具有参考价值。
  • 5年随访数据提示PCI患者需关注晚期非围术期心梗和重复血运重建风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The optimal revascularization strategy for patients with left main coronary artery disease is still controversial. This is systematic review and meta-analysis aims to evaluate the outcomes of percutaneous coronary intervention (PCI) with drug-eluting stents compared with coronary artery bypass graft (CABG) for LM disease. METHODS: Online electronic databases were systematically reviewed until January 2020 for randomized trials comparing PCI with drug-eluting stents and CABG. Primary outcomes were: all-cause mortality, myocardial infarction (MI), stroke, and repeated revascularization. Secondary outcomes included periprocedural and nonperiprocedural MI. The period of follow-up included 30 days, 1 year, and 5 years. Odds ratio and 95% confidence interval were calculated with a fixed-effects model. RESULTS: A total of 4595 patients (5 randomized trials) with left main coronary artery disease were included. At 30 days and 1 year, PCI was associated with lower incidence of stroke, higher repeated revascularization, and similar odds of mortality and MI compared with CABG. At 5 years, PCI was associated with higher rates of MI (odds ratio, 1.43; 95% confidence interval, 1.13-1.79; P = .003) and repeat revascularization (odds ratio, 1.89; 95% CI, 1.58-2.26; P < .001) than CABG. PCI was associated with lower periprocedural MI at 30 days, whereas at 5 years PCI was associated with higher nonperiprocedural MI (odds ratio, 2.32; 95% confidence interval, 1.62-3.31; P < .001). Mortality and stroke rate did not differ at 5-year follow-up. CONCLUSIONS: Patients with left main coronary artery disease treated with either PCI or CABG do not show significant difference in early or 5-year mortality. Although CABG was associated with higher stroke rates at 30 days and 1 year, PCI was associated with an increase in MI and need for repeat revascularization at 5 years.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Gallo M, Blitzer D, Laforgia PL, et al. Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: A meta-analysis. J Thorac Cardiovasc Surg. 2020. PMID: 32499076. doi:10.1016/j.jtcvs.2020.04.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。